clinical trial · NCT05891262
A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants
Bristol-Myers Squibb·phase1·completed·n = 15
Healthy Female VolunteersBMS-986196Loestrin
brief summary
The purpose of this study is to evaluate the effect of BMS-986196 when coadministered with combined hormonal oral contraceptives (ethinyl estradiol \[EE\] and norethindrone \[NET\]) in healthy female participants.
started
Jun 6, 2023
primary completion
Aug 25, 2023
completion
Aug 25, 2023
last updated
Sep 25, 2023
official title
A Phase 1, Single-center, Open-label, Single-sequence Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 With Oral Contraceptives in Healthy Female Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol